Epitopea is a seed startup based in United Kingdom. 1 investor tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
Epitopea is a UK-based cancer immunotherapy company developing vaccines targeting novel, shared tumour-specific antigens (TSAs) to treat a broad range of cancers.
Stage
seed
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky